Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Quattrone, D; Reininghaus, U; Richards, AL; Tripoli, G; Ferraro, L; Quattrone, A; Marino, P; Rodriguez, V; Spinazzola, E; Gayer-Anderson, C; Jongsma, HE; Jones, PB; La Cascia, C; La Barbera, D; Tarricone, I; Bonora, E; Tosato, S; Lasalvia, A; Szoke, A; Arango, C; Bernardo, M; Bobes, J; Del Ben, CM; Menezes, PR; Llorca, PM; Santos, JL; Sanjuan, J; Arrojo, M; Tortelli, A; Velthorst, E; Berendsen, S; de Haan, L; Rutten, BPF; Lynskey, MT; Freeman, TP; Kirkbride, JB; Sham, PC; O'Donovan, MC; Cardno, AG; Vassos, E; van Os, J; Morgan, C; Murray, RM; Lewis, CM; Di Forti, M; EU-GEI Collaborators.

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

Translational Psychiatry. 2021; 11(1): Nº de citas: 11 [doi:10.1038/s41398-021-01526-0]

Martin-Babarro, J; Toldos, MP; Paredes-Becerra, L; Abregu-Crespo, R; Fernandez-Sanchez, J; Diaz-Caneja, CM.

Association of Different Forms of Child Maltreatment With Peer Victimization in Mexican Children and Adolescents

FRONTIERS IN PSYCHOLOGY. 2021; 12: 662121-662121 Nº de citas: 10 [doi:10.3389/fpsyg.2021.662121]

Verdolini, N; Amoretti, S; Mezquida, G; Cuesta, MJ; Pina-Camacho, L; Garcia-Rizo, C; Lobo, A; Gonzalez-Pinto, A; Merchan-Naranjo, J; Corripio, I; Salagre, E; Baeza, I; Berge, D; Garriga, M; Bioque, M; Vallespir, C; Serra, M; Vieta, E; Bernardo, M.

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 49: 54-68 Nº de citas: 9 [doi:10.1016/j.euroneuro.2021.03.015]

Bralten, J; Mota, NR; Klemann, CJHM; De Witte, W; Laing, E; Collier, DA; de Kluiver, H; Bauduin, SEEC; Arango, C; Ayuso-Mateos, JL; Fabbri, C; Kas, MJ; van der Wee, N; Penninx, BWJH; Serretti, A; Franke, B; Poelmans, G.

Genetic underpinnings of sociability in the general population

NEUROPSYCHOPHARMACOLOGY. 2021; 46(9): 1627-1634 Nº de citas: 34 [doi:10.1038/s41386-021-01044-z]

Velthorst, E; Mollon, J; Murray, RM; de Haan, L; Germeys, IM; Glahn, DC; Arango, C; van der Ven, E; Di Forti, M; Bernardo, M; Guloksuz, S; Delespaul, P; Mezquida, G; Amoretti, S; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Santos, JL; Jimenez-Lopez, E; Sanjuan, J; Aguilar, EJ; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Atbasoglu, C; Saka, MC; Ucok, A; Alptekin, K; Akdede, B; Binbay, T; Altinyazar, V; Ulas, H; Yalincetin, B; Gumus-AkaY, G; Beyaz, BC; Soygur, H; Cankurtaran, ES; Kaymak, SU; Maric, NP; Mihaljevic, MM; Petrovic, SA; Mirjanic, T; Del-Ben, CM; Ferraro, L; Gayer-Anderson, C; Jones, PB; Jongsma, HE; Kirkbride, JB; La Cascia, C; Lasalvia, A; Tosato, S; Llorca, PM; Menezes, PR; Morgan, C; Quattrone, D; Menchetti, M; Selten, JP; Szoke, A; Tarricone, I; Tortelli, A; McGuire, P; Valmaggia, L; Kempton, MJ; van der Gaag, M; Riecher-Rossler, A; Bressan, RA; Barrantes-Vidal, N; Nelson, B; McGorry, P; Pantelis, C; Krebs, MO; Ruhrmann, S; Sachs, G; Rutten, BPF; van Os, J; Alizadeh, BZ; van Amelsvoort, T; Bartels-Velthuis, AA; Bruggeman, R; van Beveren, NJ; Luykx, JJ; Cahn, W; Simons, CJP; Kahn, RS; Schirmbeck, F; van Winkel, R; Reichenberg, A; EU-GEI High Risk Study.

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

MOLECULAR PSYCHIATRY. 2021; 26(8): 4529-4543 Nº de citas: 31 [doi:10.1038/s41380-020-00969-z]

Crutel, V; Lambert, E; Penelaud, PF; Severo, CA; Fuentes, J; Rosier, A; Hervas, A; Marret, S; Oliveira, G; Parellada, M; Kyaga, S; Gouttefangeas, S; Bertrand, M; Ravel, D; Falissard, B.

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2021; 51(8): 2959-2972 Nº de citas: 16 [doi:10.1007/s10803-020-04709-8]

Werhahn, JE; Mohl, S; Willinger, D; Smigielski, L; Roth, A; Hofstetter, C; Stampfli, P; Naaijen, J; Mulder, LM; Glennon, JC; Hoekstra, PJ; Dietrich, A; Deters, RK; Aggensteiner, PM; Holz, NE; Baumeister, S; Banaschewski, T; Saam, MC; Schulze, UME; Lythgoe, DJ; Sethi, A; Craig, MC; Mastroianni, M; Sagar-Ouriaghli, I; Santosh, PJ; Rosa, M; Bargallo, N; Castro-Fornieles, J; Arango, C; Penzo, MJ; Zwiers, MP; Franke, B; Buitelaar, JK; Walitza, S; Brandeis, D.

Aggression subtypes relate to distinct resting state functional connectivity in children and adolescents with disruptive behavior

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(8): 1237-1249 Nº de citas: 31 [doi:10.1007/s00787-020-01601-9]

Cleynen, I; Engchuan, W; Hestand, MS; Heung, T; Holleman, AM; Johnston, HR; Monfeuga, T; McDonald-McGinn, DM; Gur, RE; Morrow, BE; Swillen, A; Vorstman, JAS; Bearden, CE; Chow, EWC; van den Bree, M; Emanuel, BS; Vermeesch, JR; Warren, ST; Owen, MJ; Chopra, P; Cutler, DJ; Duncan, R; Kotlar, AV; Mulle, JG; Voss, AJ; Zwick, ME; Diacou, A; Golden, A; Guo, TW; Lin, JR; Wang, T; Zhang, ZD; Zhao, YJ; Marshall, C; Merico, D; Jin, A; Lilley, B; Salmons, HI; Tran, O; Holmans, P; Pardinas, A; Walters, JTR; Demaerel, W; Boot, E; Butcher, NJ; Costain, GA; Lowther, C; Evers, R; van Amelsvoort, TAMJ; van Duin, E; Vingerhoets, C; Breckpot, J; Devriendt, K; Vergaelen, E; Vogels, A; Crowley, TB; McGinn, DE; Moss, EM; Sharkus, RJ; Unolt, M; Zackai, EH; Calkins, ME; Gallagher, RS; Gur, RC; Tang, SX; Fritsch, R; Ornstein, C; Repetto, GM; Breetvelt, E; Duijff, SN; Fiksinski, A; Moss, H; Niarchou, M; Murphy, KC; Prasad, SE; Daly, EM; Gudbrandsen, M; Murphy, CM; Murphy, DG; Buzzanca, A; Di Fabio, F; Digilio, MC; Pontillo, M; Marino, B; Vicari, S; Coleman, K; Cubells, JF; Ousley, OY; Carmel, M; Gothelf, D; Mekori-Domachevsky, E; Michaelovsky, E; Weinberger, R; Weizman, A; Kushan, L; Jalbrzikowski, M; Armando, M; Eliez, S; Sandini, C; Schneider, M; Bena, FS; Antshel, KM; Fremont, W; Kates, WR; Belzeaux, R; Busa, T; Philip, N; Campbell, LE; McCabe, KL; Hooper, SR; Schoch, K; Shashi, V; Simon, TJ; Tassone, F; Arango, C; Fraguas, D; Garcia-Minaur, S; Morey-Canyelles, J; Rosell, J; Suner, DH; Raventos-Simic, J; Epstein, MP; Williams, NM; Bassett, AS; Int 22q112DS Brain Behav Consortiu.

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

MOLECULAR PSYCHIATRY. 2021; 26(8): 4496-4510 Nº de citas: 88 [doi:10.1038/s41380-020-0654-3]

Balhara, YPS; Szerman, N; Singh, S; Raga, JM; Salom, C; Peris, L; Ganesh, R.

Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey

JOURNAL OF DUAL DIAGNOSIS. 2021; 17(3): 248-256 Nº de citas: 4 [doi:10.1080/15504263.2021.1940413]

Bernardo M; Amoretti S; Cuesta MJ; Parellada M; Mezquida G; 2EPs Group; González-Pinto A; Bergé D; Lobo A; Aguilar EJ; Usall J; Corripio I; Bobes J; Rodríguez-Jiménez R; Sarró S; Contreras F; Ibáñez Á; Gutiérrez M; Micó JA.

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design.

Revista De Psiquiatria Y Salud Mental. 2021; 14(3): 164-176 Nº de citas: 3 [doi:10.1016/j.rpsmen.2021.08.001]

Penuelas-Calvo, I; Palomar-Ciria, N; Porras-Segovia, A; Miguelez-Fernandez, C; Baltasar-Tello, I; Perez-Colmenero, S; Delgado-Gomez, D; Carballo, JJ; Baca-Garcia, E.

Impact of ADHD symptoms on family functioning, family burden and parents' quality of life in a hospital area in Spain

EUROPEAN JOURNAL OF PSYCHIATRY. 2021; 35(3): 166-172 Nº de citas: 7 [doi:10.1016/j.ejpsy.2020.10.003]

Bernardo, M; Amoretti, S; Cuesta, MJ; Parellada, M; Mezquida, G; 2EPs Grp.

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

REVISTA DE PSIQUIATRIA Y SALUD MENTAL. 2021; 14(3): 164-176 Nº de citas: 10 [doi:10.1016/j.rpsm.2020.07.004]

Jongsma, HE; Gayer-Anderson, C; Tarricone, I; Velthorst, E; van der Ven, E; Quattrone, D; di Forti, M; Menezes, PR; Del-Ben, CM; Arango, C; Lasalvia, A; Berardi, D; La Cascia, C; Bobes, J; Bernardo, M; Sanjuaan, J; Santos, JL; Arrojo, M; de Haan, L; Tortelli, A; Szoke, A; Murray, RM; Rutten, BP; van Os, J; Morgan, C; Jones, PB; Kirkbride, JB; EU-GEI WP2 Grp.

Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study

PSYCHOLOGICAL MEDICINE. 2021; 51(9): 1536-1548 Nº de citas: 70 [doi:10.1017/S003329172000029X]

Siafis, S; Rodolico, A; Ciray, O; Murphy, DG; Parellada, M; Arango, C; Leucht, S.

Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder

Brain Sciences. 2021; 11(7): Nº de citas: 4 [doi:10.3390/brainsci11070908]

Pretzsch, CM; Floris, DL; Voinescu, B; Elsahib, M; Mendez, MA; Wichers, R; Ajram, L; Ivin, G; Heasman, M; Pretzsch, E; Williams, S; Murphy, DGM; Daly, E; McAlonan, GM.

Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin

Molecular Autism. 2021; 12(1): 49-49 Nº de citas: 12 [doi:10.1186/s13229-021-00454-6]

Diaz-Caneja, CM; State, MW; Hagerman, RJ; Jacquemont, S; Marin, O; Bagni, C; Umbricht, D; Simonoff, E; de Andres-Trelles, F; Kaale, A; Pandina, G; Gomez-Mancilla, B; Wang, P; Cusak, J; Siafis, S; Leucht, S; Parellada, M; Loth, E; Charman, T; Buitelaar, JK; Murphy, D; Arango, C.

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 48: 49-88 Nº de citas: 36 [doi:10.1016/j.euroneuro.2021.02.020]

McCracken, JT; Anagnostou, E; Arango, C; Dawson, G; Farchione, T; Mantua, V; McPartland, J; Murphy, D; Pandina, G; Veenstra-VanderWeele, J; ISCTM ECNP ASD Working Grp.

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 48: 3-31 Nº de citas: 48 [doi:10.1016/j.euroneuro.2021.05.010]

Szerman, N; Arias, F; Algorta, J; Basurte, I; Vega, P; Roncero, C; Martinez-Raga, J; Grau-Lopez, L.

Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder

ACTAS ESPANOLAS DE PSIQUIATRIA. 2021; 49(4): 135-144 Nº de citas: 1